InspireMD (NSPR) Announces Senior Leadership Changes
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
InspireMD Announces Senior Leadership Changes to Support Commercial Growth Initiatives
October 3, 2023 7:00 AM EDTAnnounces hiring of Patrick Verta, MD, as Executive VP of Clinical and Medical Affairs
Cheryl Tal joins as VP of Quality Assurance and Regulatory Affairs
Shane Gleason, current General Manager of North America & VP of Global Marketing, promoted to Chief Commercial Officer
Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
TEL AVIV, Israel and MIAMI, Oct. 03, 2023 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard Embolic Prevention Stent System (EPS) for the prevention of... More
